Promoting Learning & Execution through Competitions | First Quality Month Activity Successfully Held in Huayi

With the development of society and the increasing awareness of public health, drug safety has become a focal point of public concern. To further enhance the quality and management standards in our production processes, Huayi held its first Quality Month activity, which successfully ended on May 31.

With the theme of "Promoting Learning through Competitions, Enhancing Execution through Evaluations", this activity aimed to strengthen staff's understanding of control measures for preventing contamination, cross-contamination, mix-up and errors, with the focus on ensuring the effective implementation of these control measures, guaranteeing the safety and compliance of the drug manufacturing process, and earnestly fulfilling our responsibility for drug safety. 

Yibai Jia, Head of Production, awarded outstanding employees who participated in the activity. This activity not only deepened staff's awareness of the importance of drug safety and quality but also reinforced their sense of fulfilling the primary responsibility for drug safety in actual work. By transforming the GMP requirements on control measures for preventing cross-contamination, mix-up and errors into competition questions, the activity further enhanced staff's execution capabilities through competition and practice with the idea of "training via competitions and execution via evaluations", which made the skills of production operation and management personnel further improved and provided strong guarantee for the company's drug production safety and quality. 

Yibai Jia also reviewed and summarized the activity, analyzing its successes and shortcomings. The conclusions drawn from this activity will serve as a basis for improving future Quality Month activities to continuously optimize the activity's content and plans.

Huayi will continue to adhere to the principle of "quality first" and extend the spirit of the Quality Month activity into daily work to persistently strengthen drug quality and safety, continuously improve the quality management system and consistently provide safer medicines to society.